Searched for
METROPOLIS LAB
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
Open to 4-5 acquisitions, but at sensible valuations: Ameera Shah, promoter and executive chairperson, Metropolis HealthcareMetropolis Healthcare is set for its next growth phase. The diagnostic chain will focus on genomics and specialty diagnostics. Strategic ac...
Metropolis Healthcare sees strong Q4 performance driven by specialty and preventive testing pushMetropolis Healthcare reported a strong Q4 with significant growth in revenue, patient volumes, and profitability, driven by a shift toward...
Metropolis Healthcare to acquire Core Diagnostics for Rs 247 crMetropolis will acquire a 100% stake in Core Diagnostics financing Rs 135.76 crores or 55% in cash and the rest Rs 111.07 through an equity...
Diagnostics chains at inflexion point: Emkay"With competitive intensity reducing after the emergence of the new normal post-pandemic, we believe Indian organised diagnostics chains st...
Dr. Lal PathLabs Q3 Results: Firm posts 54% jump in profit on flu, COVID testsThe October-December quarter encompasses the tail end of the monsoon as well as winter, which brings with them ailments such as influenza a...
'Competition intensity in diagnostics moderating'In the first half of 2023-24, the company's core revenue, excluding Covid-19 and allied tests and government contracts, grew 13%. The volum...
Metropolis is gearing up to serve a larger segment of consumers: Ameera Shah, MDIt plans to achieve this by adding 90 more labs and 1,800 collection centres in tier-2 and tier-3 locations in the next 2-3 years, and inve...
Big Movers on D-St: What should investors do with Dr Lal Pathlabs, Metropolis Healthcare and MRPL?Stocks that were in focus include names like Dr Lal PathLabs, which was down more than 6 per cent, Metropolis Healthcare fell more than 9 p...
Metropolis looks to expand lab networkIn addition, the Mumbai-based company said it is also investing in digitalisation to enhance productivity, consumer engagement and research...
Diagnostic chain Metropolis says ramping up labs, collection centresAs on September 30, Metropolis operates 132 labs and 3006 collection centres. It plans to end FY22 by adding at least 25 laboratories
Metropolis Health to file DRHP to raise Rs 2,000 crThe diagnostic market in India is about $8 bn, and growing at a CAGR of 12 per cent.
Metropolis eyes SRL in spinoff dealMetropolis was exploring a consolidation deal which could make it the largest diagnostics chain in Asia’s third-largest economy, sources sa...
Metropolis Healthcare plans Rs 100 crore expansionCurrently, the lab chain has 2,000 collection centres and 150 labs across the country and Sri Lanka, Kenya, Mauritius and Ghana.
Entrepreneur Velu back in diagnosticsThe re-entry puts him in direct competition with his former partner, Ameera Shah.
Metropolis acquires Sanjeevani Pathology Labs in an all-cash transactionMetropolis has adopted a string of pearls strategy by either partnering or acquiring smaller brands in newer markets.
- Metropolis setup its 7th Greenfield project in Ahmedabad
Metropolis Healthcare, a chain of diagnostic centers ventured into Ahmedabad with its Greenfield project, along with its local partner unde...
- Metropolis to expand local, global ops
Metropolis Health Services is in expansion mode. The Mumbai-based chain of testing laboratories is looking to increase its presence in nort...
- Metropolis eyes 60% stake in London path lab chain
Metropolis is also exploring options for acquisitions in India and has set aside a corpus of about Rs 70 crore for this.
- Metropolis acquires two labs in Gujarat
Lab chain Metropolis Health Services, offering services from the north to the south, has completed two acquisitions in Ahmedabad.